SCHEMBL8335168

SCHEMBL8335168

N=C(N)N(c1c(O)ccc2ccccc12)c1ccc2c3c(cccc13)C=C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.40
PTPN22 Q9Y2R2 1/20 0.34
SIGMAR1 Q99720 3/20 0.34
CYP1A2 P05177 3/20 0.34
CYP2C19 P33261 2/20 0.34
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
POLB P06746 2/20 0.33
P2RX4 Q99571 1/20 0.32
CES1 P23141 1/20 0.32
USP2 O75604 1/20 0.32
PAK1 Q13153 1/20 0.32
CYP2C9 P11712 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9112765 0.82 SIGMAR1 (0.33) SIGMAR1
SCHEMBL9112697 0.76 CHEK1 (0.41) SIGMAR1ALDH1A1HSD17B10TDP1
SCHEMBL8400949 0.76
SCHEMBL6155369 0.75 SIGMAR1 (0.31) SIGMAR1
SCHEMBL8843698 0.73 SIGMAR1 (0.33) SIGMAR1
SCHEMBL6154831 0.72 KDM4E (0.40) KDM4EMAPTALDH1A1GAA
SCHEMBL6158953 0.72 SIGMAR1 (0.39) SIGMAR1
SCHEMBL8334176 0.72 IDO1 (0.38) SIGMAR1CYP1A2KDM4EMAPTALDH1A1
SCHEMBL8401688 0.71
SCHEMBL9112654 0.71 CHEK1 (0.36) SIGMAR1ALDH1A1P2RX4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO disclosed